Cargando…

Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1

Detalles Bibliográficos
Autores principales: Yergey, Alfred L., Blank, Paul S., Cologna, Stephanie M., Backlund, Peter S., Porter, Forbes D., Darling, Allan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794161/
https://www.ncbi.nlm.nih.gov/pubmed/29390035
http://dx.doi.org/10.1371/journal.pone.0192424
_version_ 1783297074398232576
author Yergey, Alfred L.
Blank, Paul S.
Cologna, Stephanie M.
Backlund, Peter S.
Porter, Forbes D.
Darling, Allan J.
author_facet Yergey, Alfred L.
Blank, Paul S.
Cologna, Stephanie M.
Backlund, Peter S.
Porter, Forbes D.
Darling, Allan J.
author_sort Yergey, Alfred L.
collection PubMed
description
format Online
Article
Text
id pubmed-5794161
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57941612018-02-16 Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 Yergey, Alfred L. Blank, Paul S. Cologna, Stephanie M. Backlund, Peter S. Porter, Forbes D. Darling, Allan J. PLoS One Correction Public Library of Science 2018-02-01 /pmc/articles/PMC5794161/ /pubmed/29390035 http://dx.doi.org/10.1371/journal.pone.0192424 Text en © 2018 Yergey et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Yergey, Alfred L.
Blank, Paul S.
Cologna, Stephanie M.
Backlund, Peter S.
Porter, Forbes D.
Darling, Allan J.
Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
title Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
title_full Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
title_fullStr Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
title_full_unstemmed Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
title_short Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
title_sort correction: characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of niemann-pick disease type c1
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794161/
https://www.ncbi.nlm.nih.gov/pubmed/29390035
http://dx.doi.org/10.1371/journal.pone.0192424
work_keys_str_mv AT yergeyalfredl correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1
AT blankpauls correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1
AT colognastephaniem correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1
AT backlundpeters correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1
AT porterforbesd correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1
AT darlingallanj correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1